Related Experiment Videos
Dangers of using "optimal" cutpoints in the evaluation of prognostic factors
D G Altman1, B Lausen, W Sauerbrei
1Medical Statistics Laboratory, Imperial Cancer Research Fund, London, England.
Journal of the National Cancer Institute
|June 1, 1994
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Minimal residual disease and outcome characteristics in infant KMT2A-germline acute lymphoblastic leukaemia treated on the Interfant-06 protocol.
European journal of cancer (Oxford, England : 1990)·2021
CONSORT 2010 statement: extension checklist for reporting within person randomised trials.
The British journal of dermatology·2019
Skeletal maturation, fundamental motor skills, and motor performance in preschool children.
Scandinavian journal of medicine & science in sports·2018
GRIPP2 reporting checklists: tools to improve reporting of patient and public involvement in research.
Research involvement and engagement·2017
GRIPP2 reporting checklists: tools to improve reporting of patient and public involvement in research.
BMJ (Clinical research ed.)·2017
Quality control of ultrasound for fetal biometry: results from the INTERGROWTH-21st Project.
Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2017
Cancer incidence trends among Asian American, Native Hawaiian, and Pacific Islander populations in the United States, 2000-2022.
Journal of the National Cancer Institute·2026
Psychological distress in adult patients with colorectal cancer: roles of biological age and neighborhood deprivation.
Journal of the National Cancer Institute·2026
A phase II randomized study of proton therapy vs intensity-modulated radiation therapy in patients with unilateral head and neck cancer.
Journal of the National Cancer Institute·2026
Cancer rarity and mortality: Evidence from a nationwide cohort study.
Journal of the National Cancer Institute·2026
Matched targeted therapy use after broad genomic profiling in advanced Non-Small cell lung cancer.
Journal of the National Cancer Institute·2026
Evaluating the incidence and predictors of chronic opioid use in early survivorship for patients with diffuse large B-cell lymphoma.
Journal of the National Cancer Institute·2026